Multimodal Prehabilitation During Chemotherapy in Patients With Colorectal Liver Metastases
Recruiting
N/A
Interventional Study
Prehabilitation
Neoadjuvant Therapy
Liver Metastases
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Supportive Care
- Participants needed
- 84 (estimated)
- Sponsor
- Institut Investigacio Sanitaria Pere Virgili · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Liver resection is the only curative treatment for patients with colorectal liver metastases (CRLM). Most patients undergo chemotherapy (CT) before liver surgery. CT objectively decreases patient functional capacity. It has already been demonstrated that a structured training program carried out during the 4 weeks following CT, while the patient is waiting for liver resection, is able to return th…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≥ 18 years
* Written informed consent obtained from subject to participate in the study.
Exclusion Criteria:
* Age \<18 years
* ASA health class status IV-V
* Mental conditions or disabling orthopedic and neuromuscular disease that prevent physical exercise or may compro…
Contacts